A detailed history of Motco transactions in Novo Nordisk A S stock. As of the latest transaction made, Motco holds 12,079 shares of NVO stock, worth $585,348. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,079
Previous 10,665 13.26%
Holding current value
$585,348
Previous $736,000 8.97%
% of portfolio
0.06%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$45.38 - $71.7 $64,167 - $101,383
1,414 Added 13.26%
12,079 $670,000
Q2 2025

Aug 01, 2025

BUY
$58.08 - $81.05 $58,370 - $81,455
1,005 Added 10.4%
10,665 $736,000
Q1 2025

May 07, 2025

BUY
$69.3 - $90.95 $56,756 - $74,488
819 Added 9.26%
9,660 $670,000
Q4 2024

Feb 05, 2025

SELL
$85.0 - $120.04 $27,200 - $38,412
-320 Reduced 3.49%
8,841 $760,000
Q3 2024

Nov 05, 2024

BUY
$119.07 - $145.42 $10,835 - $13,233
91 Added 1.0%
9,161 $1.09 Million
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $165,781 - $198,475
-1,351 Reduced 12.96%
9,070 $1.29 Million
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $91,796 - $122,192
-899 Reduced 7.94%
10,421 $1.34 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $657,121 - $789,398
7,486 Added 195.25%
11,320 $1.17 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $324,655 - $712,357
3,570 Added 1352.27%
3,834 $348,000
Q2 2023

Aug 04, 2023

BUY
$155.98 - $172.65 $41,178 - $45,579
264 New
264 $42,000
Q1 2019

May 02, 2019

SELL
$46.36 - $52.63 $46 - $52
-1 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$41.54 - $47.25 $41 - $47
1 New
1 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Motco Portfolio

Follow Motco and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.